GPCRStructure Therapeutics Inc. American Depositary Shares

NAS · US · Healthcare · Biotechnology · structuretx.com

49.09USD-9.31%Mkt Cap: 3.50B $P/E: —3d ago

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States…

Headline	Source	Time
Older
Structure Therapeutics (GPCR) Is A Hidden Biotech Multibagger Stock To Buy Now	IInsider Monkey	Jul 3
After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching	24/7 Wall St.	Jun 24
H.C. Wainwright Reiterates Buy Rating for Structure Therapeutics (GPCR)	IInsider Monkey	Jun 17
Structure Therapeutics (GPCR) Reports Positive Phase 2 Weight Loss Data for Aleniglipron	IInsider Monkey	Jun 8
Does Phase 2b Oral GLP-1 Data on Aleniglipron Change The Bull Case For Structure Therapeutics (GPCR)?	Simply Wall St.	Jun 7
If Viking Therapeutics Is Acquired, Here’s Who Wins	24/7 Wall St.	May 26

GPCRStructure Therapeutics Inc. American Depositary Shares

Industry Peers